ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Single-arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma Who Are Not Suitable for Stem Cell Transplantation or Multiagent Chemotherapy
EudraCT number 2013-000232-10
Protocol number C25007
Sponsor Millennium Pharmaceuticals, Inc,40 Landsdowne Street,Cambridge, MA,02139
Indications Hemato-oncology
Diagnosis Hodgkin Lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2013
Date of approval by Institute (SÚKL) 2.10.2013
Date of approval by EC 2.10.2013
Date of initiation CT in ČR 14.4.2014
Date of ending CT in ČR 25.5.2020
Notice
Sites FN Brno a LF MU,Interni hematologicka a onkologicka klinika ,Jihlavska 20,Brno ,625 00
Vseobecna fakultni nemocnice v Praze ,Interni klinika- klinika hematologie,U nemocnice 2,Praha 2,128 08
Fakultni nemocnice Kralovske Vinohrady ,Interni hematologicka klinika,Srobarova 50,Praha ,100 34 (discontinued)

‹‹ Back to list